As 2024 draws to a close, we’ve put together a snapshot of some of our key research stories and events that we hosted over the year.
A massive THANK YOU to all our Read more
New research has found a change to the chemotherapy regimen for people with Hodgkin lymphoma could reduce the long-term health impacts from treatment.Read more
Research from the University of Cambridge’s Cardiovascular Epidemiology Unit and funded by NIHR Cambridge BRC are listed in the top five most-cited papers in the European Heart Journal over 2023.Read more